Trial
NCT03081039
A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Louisville
Collaborators
—
Condition
Intrahepatic Cholangiocarcinoma
Intervention
Carboplatin
Why stopped
Competing study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-02-19